Gara Jalqabaatti › Lymphoma › New York › New York City
Qorannoo klinikaalii Lymphoma New York City, NY keessatti
Qorannoo 33 Lymphoma f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Columbia University, New York
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering Cancer Center, New York
Epco, Zanu, Ritux for R/R FL or MZL
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering Cancer Center, New York
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Cornell, New York
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, New York
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
DALY II USA/ MB-CART2019.1 for DLBCL
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering, New York
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Namoota walitti qabaa jiraSadarkaa 1/2
- Call for Information (Investigational Site 0031), New York
CD4CAR for CD4+ Leukemia and Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Albert Einstein Health Network, New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
Namoota walitti qabaa jiraSadarkaa 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
Namoota walitti qabaa jiraSadarkaa 2
- Columbia University Irving Medical Center, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of CAR-T Therapy in Older Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering, New York
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Namoota walitti qabaa jiraSadarkaa 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Namoota walitti qabaa jiraQorannoo ilaalaa
- Memorial Sloan Kettering Cancer Center, New York
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Namoota walitti qabaa jira
- Columbia University, New York
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Namoota walitti qabaa jiraSadarkaa 1
- Columbia University Irving Medical Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Namoota walitti qabaa jira
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Qorannoo Lymphoma magaalota biroo keessatti
- Houston, TXQorannoo 34
- Boston, MAQorannoo 33
- Washington, DCQorannoo 23
- Baldwin Park, CAQorannoo 21
- Chicago, ILQorannoo 20
- Durham, NCQorannoo 17
- St. Louis, MOQorannoo 15
- Philadelphia, PAQorannoo 15
- Cleveland, OHQorannoo 14
- Edison, NJQorannoo 12
- Atlanta, GAQorannoo 12
- Seattle, WAQorannoo 12
Qorannoo biroo New York City keessatti
- Saree OljooQorannoo 136
- Kansara Qara'a Non-Small CellQorannoo 121
- Saree (Gosoota Hunda)Qorannoo 109
- Kansarii ProstateQorannoo 103
- Kansara MetastatikiiQorannoo 93
- Kansarii ColorectalQorannoo 78
- Kansarii OvariiQorannoo 69
- Dhibee QaraQorannoo 60
- Myeloma Baay’eeQorannoo 60
- Kansarii PancreasQorannoo 60
- Kansa EndometiriyaaliiQorannoo 52
- Leukemia Myeloidii HamaaQorannoo 51
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.